Literature DB >> 2768594

Cytophagic histiocytic panniculitis is not always fatal.

J W White1, R K Winkelmann.   

Abstract

Two patients with benign cytophagic histiocytic panniculitis are presented and compared with the one benign and ten fatal cases previously reported. Benign-appearing histiocytes which engulf blood cells, nuclear debris, and platelets are the most characteristic feature of the disease. This cytophagia tends to be massive in the subcutaneous tissue and involves extracutaneous organs only in the fatal cases. The course is chronic in the benign form. Patients with the fatal form tend to have fever, hepatosplenomegaly, serosal effusions, ecchymoses, peripheral adenopathy, and mucosal ulcers. Anemia, leukopenia, elevated liver enzyme levels, and coagulopathy are present in almost all and hypocalcemia in many patients with a fatal course. Cytophagic histiocytic panniculitis may represent a form of regional histiocytosis primarily involving subcutaneous tissue. It is midway in the spectrum of the cytophagic histiocytoses.

Entities:  

Mesh:

Year:  1989        PMID: 2768594     DOI: 10.1111/j.1600-0560.1989.tb00028.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  A case of cytophagic histiocytic panniculitis: successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A.

Authors:  S Nakane; Y Kawabe; K Eguchi; A Kita; A Mizokami; H Yamasaki; S Nagataki
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

2.  Cytophagic Histiocytic Panniculitis (CHP) in a Patient with SLE Found after Autopsy: When a Rash Is "Complicated!"

Authors:  Hafsa Abbas; Ahsan Aslam; Muhammad Saad; Masooma Niazi; Sridhar Chilimuri
Journal:  Case Rep Dermatol Med       Date:  2019-07-03

3.  Cytophagic histiocytic panniculitis, hemophagocytic lymphohistiocytosis and undetermined autoimmune disorder: reconciling the puzzle.

Authors:  Claudia Pasqualini; Mauro Jorini; Ines Carloni; Mirella Giangiacomi; Valentina Cetica; Maurizio Aricò; Fernando Maria de Benedictis
Journal:  Ital J Pediatr       Date:  2014-02-13       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.